Stem cell transplantation is an effective treatment option for patients with severe systemic sclerosis, but is associated with toxicity and treatment-related mortality. Patient selection and comprehensive cardiopulmonary screening are critical factors in determining outcome. PubMed, Curr Opin Rheumatol. 2013 Nov;25(6):719-25. (Also see: Stem Cell Transplantation)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.